Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen prophylaxis for close contacts of seasonal influenza
ChiCTR2400084548Phase 4Not yet recruiting
- Sponsor
- Hebei Yiling Hospital
- Start
- May 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingwen in influenza (2 arms), sponsored by Hebei Yiling Hospital. Primary endpoint: Secondary infection risk within 9 days. Planned start May 2024; status: not yet recruiting.
02
Drugs
Lianhua Qingwen
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2400084548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084548.